​​Balancing the Future Podcast Episode Two​

Revolutionizing Research with 3D Cell Culture Applications

The advent of 3D cell culture technology is significantly transforming the landscape of drug discovery. Traditionally, drug testing relied heavily on 2D cell cultures, which often fail to accurately replicate the complexities of human biology.

In this episode of "Balancing the Future," hosts Dana Clémençon and Micah Schweizer sit down with Dr. Jan Lichtenberg, CEO and co-founder of InSphero, to investigate the revolutionary world of 3D cell culture technology. Dr. Lichtenberg shares insights into how his company develops 3D cell-based models that improve drug testing for pharmaceutical and biotech industries, highlighting their ability to provide more predictive results compared to traditional 2D cultures.

As the episode unfolds, the hosts and Dr. Lichtenberg reflect on the current landscape of drug development, regulatory challenges, and the importance of patient diversity in testing and personalized medicine. With a focus on innovation, this episode offers a compelling look at how 3D cell cultures are poised to change the future of medicine. Join us for an engaging discussion that balances science, technology, and the drive to improve healthcare. 

Key Highlights:

• Advantages, potentials, and impacts of 3D cell culture technology in drug testing and development

• Insights into the current regulatory challenges 

• Future applications in regenerative medicine, including organ replacement and addressing rare diseases

• Entrepreneurial journey and the importance of understanding market needs before launching innovations

Listen to the episode now on your favorite streaming platform: Spotify, Apple Podcasts, YouTube.